As filed with the Securities and Exchange Commission on February 27, 2019
Registration
No. 333-
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM
S-8
REGISTRATION STATEMENT
UNDER
THE
SECURITIES ACT OF 1933
Intellia Therapeutics, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
Delaware
|
|
36-4785571
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
40 Erie Street, Suite 130
Cambridge, Massachusetts (857)
285-6200
(Address, including zip code and telephone number, including area code, of Registrants principal executive offices)
Intellia Therapeutics, Inc. 2015 Amended and Restated Stock Option and Incentive Plan
Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan
(Full title of the plans)
John Leonard,
M.D.
President and Chief Executive Officer
40 Erie Street, Suite 130
Cambridge, Massachusetts
(857)
285-6200
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
|
|
|
Arthur R. McGivern, Esq.
William D. Collins, Esq.
Goodwin Procter LLP
100 Northern Ave.
Boston,
Massachusetts 02210
(617)
570-1000
|
|
José E. Rivera, Esq.
Executive Vice President, General Counsel
Intellia Therapeutics, Inc.
40 Erie Street, Suite 130
Cambridge, Massachusetts
(857)
285-6200
|